Results 51 to 60 of about 405 (144)

Spontaneous bacterial peritonitis due to carbapenemase-producing Enterobacteriaceae: Etiology and antibiotic treatment [PDF]

open access: yes, 2020
Carbapenem antibiotics were first introduced in the 1980s and have long been considered the most active agents for the treatment of multidrug-resistant gram-negative bacteria.
Alfieri A.   +7 more
core   +1 more source

Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia: a systematic review and meta-analysis [PDF]

open access: yes, 2023
Background Cefiderocol is a last resort option for carbapenem-resistant (CR) Gram-negative bacteria, especially metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa and CR Acinetobacter baumannii.
Karakonstantis, S.   +3 more
core   +1 more source

Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion [PDF]

open access: yes, 2022
Antimicrobial resistance represents a serious threat for global health, causing an unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in 2017, carbapenem-resistant organisms were listed by the WHO among the group of
Atripaldi L.   +20 more
core   +1 more source

In vitro activity of cefepime-enmetazobactam on carbapenem-resistant Gram negatives

open access: yesClinical Microbiology and Infection
Cefepime-enmetazobactam is a new β-lactam/βlactamase inhibitor combination with broad-spectrum activity against multidrug-resistant Enterobacterales, including extended-spectrum β-lactamase producers. This study evaluated the in vitro activity of cefepime-enmetazobactam towards a collection of carbapenem-resistant Enterobacterales (CRE), Pseudomonas ...
Rémy A, Bonnin   +4 more
openaire   +2 more sources

The potential of ethanol extract of white pomegranate leaves (Punica granatum L) as anti-bacterial [PDF]

open access: yes, 2020
Treatment of infections using penicillin-derived antibiotics such as methicillin has been found to cause antibiotic-resistant bacteria. This bacteria could produce a beta-lactamase enzyme to form a resistant strain.
Arnawa, I Gede Putu   +2 more
core   +1 more source

Boronate-Based Inhibitors of Penicillin-Binding Proteins: An Underestimated Avenue for Antibiotic Discovery? [PDF]

open access: yes
Penicillin-binding proteins (PBPs) are essential enzymes involved in bacterial cell wall biosynthesis and represent the primary targets of β-lactam antibiotics.
Emilia Caselli   +4 more
core   +1 more source

Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: a systematic review and meta-analysis [PDF]

open access: yes
Objectives: To meta-analyze the clinical efficacy of piperacillin-tazobactam vs. carbapenems for treating hospitalized patients affected by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales bloodstream infections (BSIs).
Cojutti, Pier Giorgio   +2 more
core   +1 more source

β-Lactam/β-Lactamase Inhibitor Combination Antibiotics Under Development

open access: yesPathogens
Antimicrobial resistance remains a public health problem of global concern with a great health and financial burden. Its recognition as a threat by political leadership has boosted the research and development of new antibiotics and particularly novel ...
Angeliki Katsarou   +4 more
doaj   +1 more source

Cefepime-Induced Encephalopathy in Patients Treated for Urinary Tract Infection [PDF]

open access: yes
Cefepime is a fourth-generation cephalosporin antibiotic administered intravenously used to treat various bacterial infections, including urinary tract infections.
Fisher, Mitchell   +4 more
core   +2 more sources

Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumannii [PDF]

open access: yes
Multicenter study[Abstract] Introduction: The rise in multidrug-resistant bacteria challenges clinical microbiology. Tigecycline, eravacycline, and omadacycline show promise against carbapenem-resistant Enterobacterales and Acinetobacter baumannii ...
Alonso-García, Isaac   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy